B. Crestani (Paris, France), A. Prasse (Hannover, Germany)
LSC - 2018 - AKT1/AKT2 mRNA Balance Is Significantly Different In IPF BAL Cells Compared To Other Fibrotic ILDs.
E. Tsitoura, E. Bibaki (bibakieleni@gmail.com / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), E. Vasarmidi (eirvasar@gmail.com / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), C. Koutoulaki (xa-ra18@gmail.com / Laboratory of Molecular and Cellular Pulmonology, M. School, U. of Crete,Heraklion), G. A. Margaritopoulos (gmargaritop@yahoo.gr / Interstitial Lung Disease Unit, R. Brompton Hospital, I. College,London), K. Karagiannis (k.karagiannis@med.uoc.gr / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), A. Proklou (proklath@gmail.com / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), A. Trachalaki (atrachalaki@gmail.com / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), D. Moraitaki (mroitaki@med.uoc.gr / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), N. Tzanakis (tzanakis@med.uoc.gr / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), A. U. Wells (rbhild@rbht.nhs.uk / Interstitial Lung Disease Unit, R. Brompton Hospital, I. College,London), K. M. Antoniou (kantoniou@med.uoc.gr / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion)
|    |
LSC - 2018 - Azithromycin reduces aSMA and leads to vacuolar formation in lung fibroblasts
R. Schliep, K. Krempaska (kristina.krempaska@dbmr.unibe.ch / Department for Biomedical Research, B. University Hospital, B. , C. , S. Barnowski (sandra.barnowski@dbmr.unibe.ch / Department for Biomedical Research, B. University Hospital, B. , C. , A. Stokes (Andrea.Stokes@insel.ch / Department for Biomedical Research, B. University Hospital, B. , C. , T. Geiser (Thomas.Geiser@insel.ch / Department for Biomedical Research, B. University Hospital, B. , C. , L. Knudsen (knudsen.lars@mh-hannover.de / Functional and Applied Anatomy Medical School Hannover,Hannover), M. Funke-Chambour (Manuela.Funke-Chambour@insel.ch / Department for Biomedical Research, B. University Hospital, B. , C.
|  |
Mesenchymal stem cells reduce ER stress via PERK-Nrf2 pathway in aged mouse model
E. LEE (Seoul, Republic of Korea), N. CáRdenes (Pittsburgh, United States of America), D. áLvarez (Pittsburgh, United States of America), J. SellaréS (Pittsburgh, United States of America), J. Sembrat (Pittsburgh, United States of America), P. Aranda (Pittsburgh, United States of America), Y. Peng (Pittsburgh, United States of America), J. Bullock (Pittsburgh, United States of America), S. Nouraie (Pittsburgh, United States of America), A. Mora (Pittsburgh, United States of America), M. Rojas (Pittsburgh, United States of America)
| |
Role of serum AGE/RAGEs in the differential diagnosis of pulmonary fibrosis
C. Machahua (L'Hospitalet de Llobregat, Spain), A. Montes-Worboys (L'Hospitalet de Llobregat, Spain), L. Planas-Cerezales (L'Hospitalet de Llobregat, Spain), R. Buendia-Flores (L'Hospitalet de Llobregat, Spain), M. Molina-Molina (L'Hospitalet de Llobregat, Spain), V. Vicens-Zygmunt (L'Hospitalet de Llobregat, Spain)
| |
17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice.
M. Yatomi (Maebashi, Japan), T. Hisada (Maebashi, Japan), Y. Hachisu (Maebashi, Japan), Y. Tsukagoshi (Maebashi, Japan), N. Kasahara (Maebashi, Japan), M. Sato (Maebashi, Japan), H. Tsurumaki (Maebashi, Japan), H. Saito (Maebashi, Japan), K. Hara (Maebashi, Japan), Y. Koga (Maebashi, Japan), N. Sunaga (Maebashi, Japan), T. Maeno (Maebashi, Japan), K. Dobashi (Maebashi, Japan)
| |
Promotion of pulmonary fibroblast migration by bile acid receptor through activation of TGF-ß1/p-Smad3 signaling pathway
X. Liu (Shanghai, China), F. Wang (Qingdao, China), H. Jiang (Shanghai, China)
| |
MUC5B is expressed by bronchoalveolar epithelia and is associated with ER stress in idiopathic pulmonary fibrosis and rheumatoid arthritis associated interstitial lung disease
J. Lee (Aurora, United States of America), E. Dobrinskikh (Aurora, United States of America), A. Estrella (Aurora, United States of America), A. Schulick (Aurora, United States of America), I. Yang (Aurora, United States of America), P. Wolters (San Frnacisco, United States of America), D. Schwartz (Aurora, United States of America)
| |
Peripheral oxidative burst correlates with VEGF serum levels in IPF: modulation by anti-fibrotic treatments
M. Bocchino (Naples, Italy), S. Zanotta (Naples, Italy), G. Rea (Naples, Italy), G. Polistina (Naples, Italy), A. Coppola (Naples, Italy), D. Galati (Naples, Italy)
| |
Upregulation of Retinoic Acid-Related Orphan Receptor-alpha (RORa) in IPF; a promising therapeutic target
E. Tsitoura (Herakleion, Greece), E. Bibaki (Herakleion, Greece), A. Koutsopoulos (Herakleion, Greece), E. Lagoudaki (Herakleion, Greece), K. Karagianni (Herakleion, Greece), N. Tzanakis (Herakleion, Greece), B. Crestani (Paris, France), K. Antoniou (Herakleion, Greece)
| |
Identification of Cell Populations with Increase Expression of Markers of Cell Senescence in Explanted IPF Lungs
M. Rojas (Pittsburgh, United States of America), N. Morse (Pittsburgh, United States of America), T. Tabib (Pittsburgh, United States of America), J. Sembrat (Pittsburgh, United States of America), K. Buschur (Pittsburgh, United States of America), H. Trejo (Pittsburgh, United States of America), T. Cruz (Pittsburgh, United States of America), L. Tu (Pittsburgh, United States of America), K. Gibson (Pittsburgh, United States of America), W. Chen (Pittsburgh, United States of America), T. Benos (Pittsburgh, United States of America), A. Mora (Pittsburgh, United States of America), R. Lafyatis (Pittsburgh, United States of America)
| |
Effect of in vivo blockade of the KCa3.1 ion channel on type II alveolar epithelial cell turnover in pulmonary fibrosis
K. Perera (Melbourne, Australia), L. Organ (Melbourne, Australia), H. Derseh (Melbourne, Australia), S. Dewage (Melbourne, Australia), A. Stent (Melbourne, Australia), K. Snibson (Melbourne, Australia)
| |
The potential use of immunomodulatory peptides from Brazilian scorpion Tityus obscurus as pharmacological therapy for Idiopathic Pulmonary Fibrosis
K. Simon (Brasília, Brazil), C. Melo-Silva, (Brasília, Brazil), P. Veloso-Junior (Brasília, Brazil), V. Amado (Brasília, Brazil), F. Cavalcante-Neto (Brasília, Brazil), A. Bocca (Brasília, Brazil)
| |
TIF1? has a protective role in pulmonary fibrosis
P. Boutanquoi (Dijon, France), G. Beltramo (Dijon, France), O. Burgy (Dijon, France), P. Bellaye (Dijon, France), L. Dondaine (Dijon, France), A. Mailleux (Paris, France), B. Crestani (Paris, France), C. Garrido (Dijon, France), F. Goirand (Dijon, France), P. Bonniaud (Dijon, France)
| |
The efficacy of Phoenix dactylifera L. sap for the treatment of lung injury in a murine model of pulmonary fibrosis
S. BAHRI (Tunis, Tunisia), R. Abdennabi (Sfax, Tunisia), R. Ben Ali (Tunis, Tunisia), M. Mlika (Tunis, Tunisia), N. Gharsallah (Athens, Greece), K. Ayed (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia)
| |
Let7c and AKT1/AKT2 mRNA balance is different In IPF BAL cells compared to other fibrotic ILDs.
E. Tsitoura (Herakleion, Greece), E. Bibaki (Herakleion, Greece), E. Vasarmidi (Herakleion, Greece), A. Trachalaki (Herakleion, Greece), C. Koutoulaki (Herakleion, Greece), G. Margaritopoulos (London, United Kingdom), K. Karagiannis (Herakleion, Greece), A. Proklou (Herakleion, Greece), D. Moraitaki (Herakleion, Greece), N. Tzanakis (Herakleion, Greece), A. Wells (London, United Kingdom), K. Antoniou (Herakleion, Greece)
| |
The profibrotic role of downregulated Na,K-ATPase ß1 subunit in alveolar epithelium cells in lung fibrosis
B. Li (Beijing, China), X. Huang (Beijing, China), X. Xu (Beijing, China), W. Ning (Tianjin, China), C. Dai (Beijing, China)
| |
Metformin attenuates bleomycin-induced pulmonary fibrosis in mice via IGF-1 suppression
h. xiao (Beijing, China), X. Huang (Beijing, China), S. Wang (Beijing, China), J. Geng (Beijing, China), D. Jiang (Beijing, China), H. Dai (Beijing, China)
| |
Plasma mitochondrial DNA as a biomarker of disease progression in idiopathic pulmonary fibrosis
H. Yoon (Seoul, Republic of Korea), H. Kim (Seoul, Republic of Korea), . Lee (Seoul, Republic of Korea), . Choi (Seoul, Republic of Korea), D. Kim (Seoul, Republic of Korea), J. Song (Seoul, Republic of Korea)
| |